NervGen Pharma: Audience

NervGen Pharma is a clinical-stage biotech company focused on developing innovative treatments for nervous system repair following traumatic injuries and diseases. Their lead drug candidate, NVG-291, is currently undergoing clinical trials for spinal cord injury.